Now What? Assessing and Pivoting in the Face of Biologic "Failure"

What’s the difference between primary and secondary failure of a biologic? And why does it matter? Exploring an actual patient case, faculty from the DEF Biologic and Small Molecule NP/PA CME Bootcamp—April Armstrong, MD, MPH; David E. Cohen, MD, MPH; Kara Gooding, MMS, PA-C; and Joe Gorelick, MSN, FNP-C—address these questions and many more. Plus, Mary Beth Hagan, Founder of TITAN Aesthetic Recruiting, gives tips for PAs and NPs interested in cosmetic dermatology, and there are changes coming to iPLEDGE for isotretinoin.

Like what you're hearing? Want to learn more about the Dermatology Education Foundation? Explore assets and resources on our website.